STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
143
13F, latest reported quarter
Conversions, 180 days
8
Codes C/M, not in net · $4.0M priced
What the filings say about HNI
Insiders, 180 days
-$4.6M net sold
1 seller · 78% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-05-08
Planned sales (Form 144), 90 days
$5.8M
7 notices
HNI insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, HNI CORP insiders sold a net $4.6M of stock across 83 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
18 earlier Form 4 trades (code P or S) here by this insider (18 sales), the last on Aug 27, 2026.
The trade is 1.0% of the 148,490 shares held after it.
No other insider sold within 30 days.
143 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO Lorenger Jeffrey D sold about $75.2K of HNI under a 10b5-1 plan on Aug 28, 2026; 143 funds added in the latest 13F quarter.
16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Aug 26, 2026.
The trade is 18.3% of the 148,490 shares held after it.
No other insider sold within 30 days.
143 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO Lorenger Jeffrey D sold about $1.4M of HNI under a 10b5-1 plan on Aug 27, 2026; 143 funds added in the latest 13F quarter.
16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Aug 26, 2026.
The trade is 8.4% of the 148,490 shares held after it.
No other insider sold within 30 days.
143 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO Lorenger Jeffrey D sold about $623.3K of HNI under a 10b5-1 plan on Aug 27, 2026; 143 funds added in the latest 13F quarter.
14 earlier Form 4 trades (code P or S) here by this insider (14 sales), the last on Aug 24, 2026.
The trade is 3.1% of the 148,490 shares held after it.
No other insider sold within 30 days.
143 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO Lorenger Jeffrey D sold about $233.8K of HNI under a 10b5-1 plan on Aug 26, 2026; 143 funds added in the latest 13F quarter.
14 earlier Form 4 trades (code P or S) here by this insider (14 sales), the last on Aug 24, 2026.
The trade is 1.9% of the 148,490 shares held after it.
No other insider sold within 30 days.
143 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO Lorenger Jeffrey D sold about $142.1K of HNI under a 10b5-1 plan on Aug 26, 2026; 143 funds added in the latest 13F quarter.
83 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
HNI planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
DAVID SYLVESTER
Filed 2026-09-22
$1.1M
DAVID SYLVESTER
Filed 2026-09-14
$26.5K
Lorenger Jeffrey D
Filed 2026-08-28
$75.2K
Lorenger Jeffrey D
Filed 2026-08-27
$2.0M
Lorenger Jeffrey D
Filed 2026-08-26
$375.9K
HNI mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
LONE PEAK VALUE FUND
$5.1M position · as of 2026-06-30
3.0%
Tarkio Fund
$7.5M position · as of 2026-05-31
2.9%
Pear tree polaris small cap fund
$1.8M position · as of 2026-06-30
1.8%
Nuveen Small Cap Select Fund
$6.4M position · as of 2026-07-31
1.6%
CRAWFORD SMALL CAP DIVIDEND FUND
$5.4M position · as of 2026-06-30
1.4%
Columbia Variable Portfolio - Select Small Cap Value Fund
$1.4M position · as of 2026-06-30
1.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Lorenger
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$7.1M
$12.5M
$1.8M
+29%
-35%
2022
$5.7M
-$1.8M
$1.4M
-16%
-56%
2021
$9.1M
$12.7M
$2.4M
+20%
-22%
2020
$4.9M
$3.4M
$1.5M
-4%
-25%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $4.6M sold by insiders over 180 days, 143 funds added last quarter, $5.8M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$4.4B
four quarters, 2025-06-29 to 2026-07-04
Revenue, TTM HNI
FY Jan 2026
$2.8B
FY Dec 2024
$2.5B
FY Dec 2023
$2.4B
FY Dec 2022
$2.4B
FY Jan 2022
$2.2B
Jul 2026
$1.5B
Apr 2026
$1.3B
Jan 2026
$888.4M
Sep 2025
$683.8M
Jun 2025
$667.1M
Mar 2025
$599.8M
Dec 2024
$642.5M
Sep 2024
$672.2M
At each fiscal year end
Single quarter
Net margin, TTM
+0.1%
net income over revenue, 2025-06-29 to 2026-07-04
Net margin, TTM HNI
FY Jan 2026
+1.9%
FY Dec 2024
+5.5%
FY Dec 2023
+2.0%
FY Dec 2022
+5.2%
FY Jan 2022
+2.7%
Jul 2026
+3.5%
Apr 2026
-2.9%
Jan 2026
-5.5%
Sep 2025
+6.0%
Jun 2025
+7.2%
Mar 2025
+2.3%
Dec 2024
+6.0%
Sep 2024
+7.1%
At each fiscal year end
Single quarter
Free cash flow, TTM
$113.3M
operating cash flow minus capex, 2025-06-29 to 2026-07-04
Free cash flow, TTM HNI
FY Jan 2026
$208.4M
FY Dec 2024
$173.8M
FY Dec 2023
$188.5M
FY Dec 2022
$12.8M
FY Jan 2022
$65.1M
Jul 2026
n/a
Apr 2026
-$207.5M
Jan 2026
$60.4M
Sep 2025
$135.6M
Jun 2025
$16.1M
Mar 2025
-$3.7M
Dec 2024
$41.5M
Sep 2024
$114.0M
At each fiscal year end
Single quarter
Debt to equity
0.76x
long-term 2026-07-04 plus current 2026-07-04; equity 2026-07-04
Debt to equity HNI
FY Jan 2026
0.70x
FY Dec 2024
0.41x
FY Dec 2023
0.57x
FY Dec 2022
0.31x
FY Jan 2022
0.30x
Jul 2026
0.76x
Apr 2026
0.81x
Jan 2026
0.70x
Sep 2025
0.39x
Jun 2025
0.55x
Mar 2025
0.50x
Dec 2024
0.41x
Sep 2024
0.41x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.15x
TTM operating cash flow over long-term 2026-07-04 plus current 2026-07-04
Cash flow to debt HNI
FY Jan 2026
0.21x
FY Dec 2024
0.66x
FY Dec 2023
0.61x
FY Dec 2022
0.43x
FY Jan 2022
0.74x
Jul 2026
0.15x
Apr 2026
0.06x
Jan 2026
0.21x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
0.66x
Sep 2024
0.81x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+0.3%
TTM net income over average of 2025-06-28 and 2026-07-04
Return on equity HNI
FY Jan 2026
+4.0%
FY Dec 2024
+17.4%
FY Dec 2023
+7.2%
FY Dec 2022
+20.5%
FY Jan 2022
+10.1%
Jul 2026
+0.3%
Apr 2026
+0.1%
Jan 2026
+4.0%
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
+17.4%
Sep 2024
+15.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.1%
TTM net income over average of 2025-06-28 and 2026-07-04
Return on assets HNI
FY Jan 2026
+1.6%
FY Dec 2024
+7.3%
FY Dec 2023
+2.9%
FY Dec 2022
+8.5%
FY Jan 2022
+4.1%
Jul 2026
+0.1%
Apr 2026
+0.0%
Jan 2026
+1.6%
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
+7.3%
Sep 2024
+6.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
effective tax rate 83%, not meaningful
Return on invested capital HNI
FY Jan 2026
+3.0%
FY Dec 2024
+14.3%
FY Dec 2023
+6.2%
FY Dec 2022
+17.3%
FY Jan 2022
+9.6%
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
+3.0%
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
+14.3%
Sep 2024
+13.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+3.4%
operating income (EBIT proxy) over average of 2025-06-28 and 2026-07-04 minus current liabilities
Return on capital employed HNI
FY Jan 2026
+4.9%
FY Dec 2024
+14.4%
FY Dec 2023
+7.3%
FY Dec 2022
+15.4%
FY Jan 2022
+8.7%
Jul 2026
+3.4%
Apr 2026
+2.5%
Jan 2026
+4.9%
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
+14.4%
Sep 2024
+12.5%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing HNI
FY Jan 2026
38.36x
FY Dec 2024
17.60x
FY Dec 2023
40.61x
FY Dec 2022
9.60x
FY Jan 2022
31.15x
Jul 2026
n/a
Apr 2026
120.26x
Jan 2026
38.36x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
17.60x
Sep 2024
20.29x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$4.7B
market value at close 2026-10-26 on 2026-07-04 shares, plus long-term 2026-07-04 plus current 2026-07-04, minus cash 2026-07-04
Enterprise value HNI
FY Jan 2026
$3.0B
FY Dec 2024
$2.8B
FY Dec 2023
$2.4B
FY Dec 2022
$1.3B
FY Jan 2022
$2.0B
Jul 2026
$4.3B
Apr 2026
$3.7B
Jan 2026
$3.0B
Sep 2025
$2.4B
Jun 2025
$2.7B
Mar 2025
$2.5B
Dec 2024
$2.8B
Sep 2024
$2.8B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+3.3%
TTM free cash flow over market value at close 2026-10-26
FCF yield HNI
FY Jan 2026
+10.7%
FY Dec 2024
+7.1%
FY Dec 2023
+9.7%
FY Dec 2022
+1.1%
FY Jan 2022
+3.6%
Jul 2026
+3.8%
Apr 2026
+0.2%
Jan 2026
+10.7%
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
+7.1%
Sep 2024
+8.8%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing HNI
FY Jan 2026
n/a
FY Dec 2024
0.10x
FY Dec 2023
n/a
FY Dec 2022
0.08x
FY Jan 2022
0.80x
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
0.10x
Sep 2024
0.12x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
HNI ranks highest on growth (72nd percentile) and risk and compliance (63rd), and lowest on insider conviction (16th), among Consumer Goods peers.
Profitability
44
Inputs
Return on equity+0.3% · 42 pct, sector of 105
Return on assets+0.1% · 46 pct, sector of 124
Return on invested capitaleffective tax rate 83%, not meaningful
Return on capital employed+3.4% · 42 pct, sector of 108
Financial health
27
Inputs
Debt to equity0.76x · 27 pct, sector of 112
Cash flow to debt0.15x · 27 pct, sector of 96
Growth
72
Inputs
Revenue growth, YoY+12.4% · 72 pct, sector of 145
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
16
Inputs
Net Form 4 buying (codes P and S), 180d-$2.2M · 32 pct, sector of 80
Insider buyers, 180d0 · 0 pct, sector of 80
Institutional and government
61
Inputs
Funds adding, latest quarter143 · 61 pct, sector of 123
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
63
Inputs
Short interest, % of float+6.0% · 40 pct, sector of 157
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 102
New text in Risk Factors, latest 10-K+14.1% · 50 pct, sector of 111
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
HNI filings, in plain words
Are HNI insiders buying or selling HNI?
In the 180 days to 2026-10-28, HNI insiders were net sellers, a net $4.6M across purchases and sales reported on Form 4, by 1 seller.
Have members of Congress traded HNI?
Yes, but not in the year to 2026-10-28; the latest on record is a sale by Jefferson Shreve dated 2025-05-08.
Are there planned insider sales of HNI?
Yes. 7 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $5.8M of stock; the latest, by DAVID SYLVESTER, was filed 2026-09-22.
Read the full summary
In the 180 days to 2026-10-28, HNI insiders were net sellers of HNI, a net $4.6M across purchases and sales reported on Form 4 by 1 seller. 78% of the 9 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Members of Congress have disclosed trades in HNI, none in the last year; the latest on record is a sale by Jefferson Shreve dated 2025-05-08. Insiders filed 7 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $5.8M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.